• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ADS
Click for more information
0.00% 0.1¢

ADSLOT LTD. - News & Media

Market Cap $4.702M  ! watchlist Created with Sketch. Add to my watchlist
Technology Software - Application

Adslot Ltd is an Australia-based company, which is focused on automating the trading of... Adslot Ltd is an Australia-based company, which is focused on automating the trading of forward guaranteed display advertising, referred to as automated guaranteed. Its principal activities include Trading Technology and Services. Trading Technology comprises Adslot Media, a global media trading technology platform, and Symphony, a workflow automation technology for media agencies. Services comprise digital marketing services provided by the Company's Webfirm division and project-based customization of Trading Technology. Adslot Media is an independent programmatic guaranteed technology that scales publisher-direct media buying through a direct connection with publisher ad servers. Symphony is the buying and planning workflow platform for media agencies. Symphony manages every step of the media buying life cycle. Adslot and Symphony provides end-to-end media planning, buying, and selling management for the advertising industry. It operates in North America, Europe, and Asia Pacific.More

No News & Media currently available.

(20min delay)
Last
0.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.702M
Open High Low Value Volume
0.1¢ 0.1¢ 0.1¢ $161 160.5K

Buyers (Bids)

No. Vol. Price($)
1 915720 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 13520596 9
View Market Depth
Last trade - 10.18am 02/10/2024 (20 minute delay) ?
ADS (ASX) Chart

Top Stories

PainChek close to finding out if FDA approves its flagship app for use in dementia care

PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.